SenoRx, Inc. Announces CE Mark to Commercialize Contura(tm) MLB in Europe
IRVINE, Calif., March 26, 2009 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that it has received the right to apply the CE Mark to its Contura(tm) MLB short-term breast radiation balloon catheter. The multi-lumen radiation balloon delivers radiation to the tissue surrounding a lumpectomy cavity following surgery for breast cancer. The CE Mark applies to both the original size Contura MLB, which is designed for lumpectomy cavities of 4 to 5 centimeters in diameter, as well as the more recently cleared, larger-size Contura Shape Select(r) MLB designed for cavities ranging from 4.5 to 6 centimeters. The CE Mark is required for sales in countries within the European Economic Community. SenoRx had previously announced the receipt of 510(k) clearance in the United States for the original Contura in May 2007 and for the larger-size Contura in July 2008.